A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...
Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Teamwork and systematic follow-up strategies among interdisciplinary staff can improve patient engagement and appointment ...
Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...
Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...
Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...
Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
Dietary counseling is an effective strategy for managing and preventing nutritional imbalances in pediatric patients with non–IgE-mediated gastrointestinal food allergies, a study shows.
The use of ketamine, midazolam, lorazepam, droperidol, and haloperidol was also assessed. Children who interacted with ...
Vestibular therapy is feasible and may alleviate dizziness symptoms among patients in the emergency department, a pilot study finds.
Implementation of the ERAS program delivers better patient outcomes, achieves shorter lengths of stay, and saves money.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results